locator iconlocator icon
All Labs
 
add to cart

Anti Nuclear Antibody

650455
30% Coupon
4.1
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
Anti Nuclear Antibody

Overview of Anti Nuclear Antibody

What is Anti Nuclear Antibody?

Antinuclear antibodies (ANA) are antibodies produced by the immune system of the body against protein markers found in the nucleus of its own cells. The Antinuclear Antibody Test screens for the presence of antinuclear antibodies (ANA) in blood.

Sample Type

The sample type collected for Anti Nuclear Antibody is: Blood

Preparation for Anti Nuclear Antibody

  • No special preparation required

Why Get Tested for Anti Nuclear Antibody?


The Antinuclear Antibody Test is performed:

·  To determine the presence of an autoimmune disease like Systemic Lupus Erythematosus (SLE)

·    To evaluate the possible presence of autoimmune Connective Tissue Disorders (CTDs) other than SLE such as Polymyositis, Scleroderma, Sjögren's syndrome etc.




Understand more about Anti Nuclear Antibody

The immune system of the body is responsible for recognition of the body’s own cells and identification of foreign cells like pathogens which are then targeted and destroyed. Autoimmune disorders are conditions where the immune system of the body is unable to recognize certain cells as the body’s own cells and starts an immune response against them which results in their destruction. The recognition of ‘self’ and ‘non-self’ cells is mediated by certain proteins present on the surface of cells or inside them. When the immune system identifies a cell as foreign or ‘non-self’, it produces antibodies against these cells to destroy them. Antibodies produced in an autoimmune disease are called autoantibodies.

Antinuclear antibodies (ANA) are autoantibodies that are produced against protein markers present in the nucleus of certain cells of the body. They are produced in a number of autoimmune diseases but are most commonly produced in Systemic Lupus Erythematosus (SLE).

The Antinuclear Antibody Test can be performed either by Immunoassay method (ELISA) or Indirect Fluorescent Antibody (IFA) method to detect ANA in blood. Both these tests may be used by some laboratories together: the Immunoassay method (ELISA) to screen for the presence of antinuclear antibodies, and IFA method subsequently to confirm the positive or equivocal Immunoassay results.

ANA by Immunoassay method (ELISA) utilizes a mixture of known anti-nuclear antigens and is fairly simple to perform, can be automated and provides fairly objective results.



What Results of Anti Nuclear Antibody mean?

Interpretations

Results are provided as positive/negative or with an index value against a cutoff value.

A positive ANA test can also be seen in healthy individuals, particularly the elderly or in diseases other than Connective Tissue Disorders (CTD), where it has no diagnostic value.


Patient Concerns about Anti Nuclear Antibody

Frequently Asked Questions about Anti Nuclear Antibody

Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
Q. Is there any risk associated with this test?
There is no risk associated with the test. However, as this test involves a needle prick to withdraw the blood sample, rarely, a patient may experience increased bleeding, hematoma (blood collection under the skin) formation, bruising or infection at the site of needle prick.
+ more

Provided By

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.

Available at Other Labs

VIEW ALL